Topiramate Curbs Binge Eating, Obesity

Susan Farley
Published Online: Tuesday, February 1, 2005

The epilepsy drug topiramate may provide long-term benefits for people with binge-eating disorder and obesity, as suggested by results of a small study from the University of Cincinnati College of Medicine. The study included 61 subjects randomly selected to receive topiramate or placebo; 44 patients received topiramate, and results were available for 43 of these patients, who reached an ending dosage of 250 mg/d. All 43 patients experienced a significant decline in the number of weekly binge-eating episodes, and they experienced a significant weight loss as well. Based on these results, the study team concluded that further studies of topiramate for the long-term treatment of binge-eating disorder are needed.

Ms. Farley is a freelance medical writer based in Wakefield, RI.

Latest Articles
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Latest Issues